CIK 0001719406
- Non-accelerated filer
- Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822844431
- Phone
- +1 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 4 Open-market buy Chief Scientist bought 100,000 shares at $58.00 ($5,800,000)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 18,300 shares (option exercise)
- 4 Gift 10% owner gave 869,188 shares (gift)
- 4 Open-market sale General Counsel & Secretary sold 33,715 shares at $13.11 ($442,004)
- 4 Open-market sale Chief Comm. & Patient Officer sold 40,000 shares at $11.76 ($470,400)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 43,093 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 14,817,329 shares (grant or award)
- 4 Grant or award 10% owner acquired 13,971,864 shares (grant or award)
- 4 Grant or award Director acquired 1,644,793 shares (grant or award)
- 4 Grant or award Director acquired 41,686 shares (grant or award)
- 4 Grant or award Director acquired 13,168 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 432,750 shares (grant or award)
- 4 Grant or award General Counsel & Secretary acquired 6,320 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 5 · 84 filings